Testing version — LOERadar is in active testing. Features and data may change.
ADENOSCAN (ADENOSINE) | LOERadar
ADENOSCAN
NDA
ADENOSINE | N020059 | ASTELLAS PHARMA US INC
2 strengths0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (2)
Sort:
#001 — 60MG/20ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
RLD
0 patents0 exclusivities▴
SOLUTION;INTRAVENOUS | Approved: May 18, 1995
No patent or exclusivity listings for this strength.
#002 — 90MG/30ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**